Duloxetine Protects against Oxaliplatin-Induced Neuropathic Pain and Spinal Neuron Hyperexcitability in Rodents

• Published in: International journal of molecular sciences 2017-12, Vol.18 (12), p.2626
• Main Authors: Kim, Woojin, Chung, Yeongu, Choi, Seunghwan, Min, Byung-Il, Kim, Sun Kwang
• Format: Article
• Language: English
• Subjects: Acetone; Adrenergic alpha-2 Receptor Antagonists - therapeutic use; Adrenergic receptors; Animals; Antidepressants; Chemotherapy; chemotherapy-induced peripheral neuropathy; Duloxetine; Duloxetine Hydrochloride - therapeutic use; In vivo methods and tests; Injection; Male; Mice; Mice, Inbred C57BL; Neuralgia - chemically induced; Neuralgia - prevention & control; Neurons - drug effects; Neurons - metabolism; noradrenergic receptor; Norepinephrine; Organoplatinum Compounds - toxicity; Oxaliplatin; Pain; Pain perception; Peripheral neuropathy; Phentolamine; Prazosin; Rats; Rats, Sprague-Dawley; Receptors (physiology); Rodents; Serotonin; Spinal Cord - cytology; wide dynamic range (WDR) cell
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms18122626

Oxaliplatin is a widely used chemotherapy agent, but induces serious peripheral neuropathy. Duloxetine is a dual reuptake inhibitor of serotonin and norepinephrine, and is shown to be effective against pain. However, whether and how duloxetine can attenuate oxaliplatin-induced allodynia in rodents is not clearly understood. A single injection of oxaliplatin (6 mg/kg, intraperitoneal; i.p.) induced a cold and mechanical allodynia, which was assessed by acetone and von Frey filament tests, respectively. When significant allodynic signs were observed, three different doses of duloxetine (10, 30, and 60 mg/kg, i.p.) were injected. Administration of 30 and 60 mg/kg of duloxetine significantly reduced the allodynia, whereas 10 mg/kg did not. By using an in vivo extracellular recording method, we further confirmed that 30 mg/kg of duloxetine could significantly inhibit the hyperexcitability of spinal wide dynamic range (WDR) cells. The anti-allodynic effect of duloxetine was completely blocked by an intrathecal injection of phentolamine (non-selective α-adrenergic receptor antagonist, 20 μg), or prazosin (α₁-adrenergic receptor antagonists, 10 μg); however, idazoxan (α₂-adrenergic receptor antagonist, 10 μg) did not block it. In conclusion, we suggest that duloxetine may have an effective protective action against oxaliplatin-induced neuropathic pain and spinal hyperexcitability, which is mediated by spinal α₁-adrenergic receptors.